Antitrematodal / cestocidal — increases parasite Ca²⁺ permeability causing tegument paralysis + disintegration. First-line for schistosomiasis, tapeworm infections (taeniasis, cysticercosis), liver flukes. Dramatic reduction in schistosomiasis burden in endemic areas via mass drug administration.
Half-Life & Elimination Curve (PO: 1.5h)
Plasma (PO)t½ Decay (1.5h)
0×t½0h100%(1.89 mg/L)
1×t½1.5h50%(0.947 mg/L)
2×t½3h25%(0.474 mg/L)
3×t½4.5h12.5%(0.237 mg/L)
4×t½6h6.3%(0.118 mg/L)
5×t½7.5h3.1%(59.2 µg/L)
Elimination t½1.5h (PO)
Rate Constant (ke)0.462 h⁻¹
Time to Peak (Tmax)1.13h
Est. Peak (Cmax)1.89 mg/L
Clearance (CL)277 L/h
97% Washout (5×t½)7.5h
Dosing Guidelines
Oral (PO): Typical 2400 mg (Range: 600–4500 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 80% · Volume of Distribution (Vd): 600 L · Absorption (ka): 1.5 h⁻¹ (t½ka ≈ 28m) [PMID 31089768]